File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Biliary tract disease as a risk factor for Plesiomonas shigelloides bacteraemia: a nine-year experience in a Hong Kong hospital and review of the literature

TitleBiliary tract disease as a risk factor for Plesiomonas shigelloides bacteraemia: a nine-year experience in a Hong Kong hospital and review of the literature
Authors
KeywordsAcute cholangitis
Bacteraemia
Biliary tract disease
Plesiomonas shigelloides
Issue Date2005
PublisherEdizioni Medico Scientifiche (EDIMES). The Journal's web site is located at http://www.microbiologica.net
Citation
New Microbiologica, 2005, v. 28 n. 1, p. 45-55 How to Cite?
AbstractWe report the epidemiology, clinical disease spectrum, treatment, and outcome of Plesiomonas shigelloides bacteraemia in our hospital over a nine-year period and compare the characteristics of patients with P. shigelloides bacteraemia in our hospital with those reported in the literature. During the nine-year period (1995-2003), a total of seven patients developed P. shigelloides bacteraemia. All cases occurred during the late spring, summer, and early autumn (May-October). All patients were over 75 and had underlying diseases (biliary tract diseases in four and malignancies in three). Six had acute cholangitis and five had polymicrobial bacteraemia. Overall two patients died. Compared with patients with P. shigelloides bacteraemia reported in the literature, patients with P. shigelloides bacteraemia in our hospital were associated with old age (P<0.001), underlying biliary tract diseases (P<0.001), acute cholangitis (P<0.001), and polymicrobial bacteraemia (P<0.001). There are major geographical differences of disease association in P. shigelloides bacteraemia. The sources of P. shigelloides in our patients were probably in the gastrointestinal tract.
Persistent Identifierhttp://hdl.handle.net/10722/157395
ISSN
2021 Impact Factor: 1.383
2020 SCImago Journal Rankings: 0.751
References

 

DC FieldValueLanguage
dc.contributor.authorWoo, PCYen_US
dc.contributor.authorLau, SKPen_US
dc.contributor.authorYuen, KYen_US
dc.date.accessioned2012-08-08T08:49:37Z-
dc.date.available2012-08-08T08:49:37Z-
dc.date.issued2005en_US
dc.identifier.citationNew Microbiologica, 2005, v. 28 n. 1, p. 45-55en_US
dc.identifier.issn1121-7138en_US
dc.identifier.urihttp://hdl.handle.net/10722/157395-
dc.description.abstractWe report the epidemiology, clinical disease spectrum, treatment, and outcome of Plesiomonas shigelloides bacteraemia in our hospital over a nine-year period and compare the characteristics of patients with P. shigelloides bacteraemia in our hospital with those reported in the literature. During the nine-year period (1995-2003), a total of seven patients developed P. shigelloides bacteraemia. All cases occurred during the late spring, summer, and early autumn (May-October). All patients were over 75 and had underlying diseases (biliary tract diseases in four and malignancies in three). Six had acute cholangitis and five had polymicrobial bacteraemia. Overall two patients died. Compared with patients with P. shigelloides bacteraemia reported in the literature, patients with P. shigelloides bacteraemia in our hospital were associated with old age (P<0.001), underlying biliary tract diseases (P<0.001), acute cholangitis (P<0.001), and polymicrobial bacteraemia (P<0.001). There are major geographical differences of disease association in P. shigelloides bacteraemia. The sources of P. shigelloides in our patients were probably in the gastrointestinal tract.en_US
dc.languageengen_US
dc.publisherEdizioni Medico Scientifiche (EDIMES). The Journal's web site is located at http://www.microbiologica.neten_US
dc.relation.ispartofNew Microbiologicaen_US
dc.subjectAcute cholangitis-
dc.subjectBacteraemia-
dc.subjectBiliary tract disease-
dc.subjectPlesiomonas shigelloides-
dc.subject.meshAgeden_US
dc.subject.meshAnti-Bacterial Agents - Therapeutic Useen_US
dc.subject.meshBacteremia - Complications - Drug Therapy - Epidemiologyen_US
dc.subject.meshBiliary Tract Diseases - Complicationsen_US
dc.subject.meshCholangitis - Complicationsen_US
dc.subject.meshFemaleen_US
dc.subject.meshGram-Negative Bacterial Infections - Complications - Drug Therapy - Epidemiology - Microbiologyen_US
dc.subject.meshHong Kong - Epidemiologyen_US
dc.subject.meshHumansen_US
dc.subject.meshMaleen_US
dc.subject.meshMicrobial Sensitivity Testsen_US
dc.subject.meshPlesiomonas - Isolation & Purificationen_US
dc.subject.meshRisk Factorsen_US
dc.subject.meshTreatment Outcomeen_US
dc.titleBiliary tract disease as a risk factor for Plesiomonas shigelloides bacteraemia: a nine-year experience in a Hong Kong hospital and review of the literatureen_US
dc.typeArticleen_US
dc.identifier.emailWoo, PCY: pcywoo@hkucc.hku.hken_US
dc.identifier.emailLau, SKP: skplau@hkucc.hku.hken_US
dc.identifier.emailYuen, KY: kyyuen@hkucc.hku.hken_US
dc.identifier.authorityWoo, PCY=rp00430en_US
dc.identifier.authorityLau, SKP=rp00486en_US
dc.identifier.authorityYuen, KY=rp00366en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.pmid15782626-
dc.identifier.scopuseid_2-s2.0-14844334591en_US
dc.identifier.hkuros114668-
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-14844334591&selection=ref&src=s&origin=recordpageen_US
dc.identifier.volume28en_US
dc.identifier.issue1en_US
dc.identifier.spage45en_US
dc.identifier.epage55en_US
dc.publisher.placeItalyen_US
dc.identifier.scopusauthoridWoo, PCY=7201801340en_US
dc.identifier.scopusauthoridLau, SKP=7401596211en_US
dc.identifier.scopusauthoridYuen, KY=36078079100en_US
dc.identifier.issnl1121-7138-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats